Order-of-magnitude gap: the company is already serving a demand source whose scale dwarfs its own current business
The model's full reasoning — Q3 2019 call → NOWe need to determine if management describes a mismatch of scale between the company and the demand it is already serving. The key is: the company is already inside a large flow, and management explicitly draws the size contrast, treating it as the point. Looking at the transcript, there are several mentions of construction opportunity. Andrew Anagnost says: "You have heard me say many times that the construction industry was a key focus area for us in becoming a design and make company. It’s hungry to deploy more technology and were ready with compelling solutions." Then later: "We are tremendously excited about joining forces with PlanGrid and I believe this will further position us for success as we move further into the 10 billion construction opportunity." That's a market size figure. But does management describe how little of it they have taken? Scott Herren says: "on the construction market, this is the -- we stated a $10 billion opportunity over time, but it's probably less than a million today. The last time we did our own survey. We thought it was around the $500 million market today." Wait, he says "less than a million" but then says "around $500 million market today." Actually he says "it's probably less than a million today" but then corrects to "around $500 million market today." So the market is $500 million today, and the opportunity is $10 billion over time. That's a large market relative to current revenue. But is the company already inside it? Yes, they have BIM 360 and now PlanGrid, they have customers, they are selling. They mention specific customers like DPR, AECOM, etc. So they are already participating. But does management draw the size contrast explicitly? Scott says: "I think a lot of its growth going ahead is not necessarily reclaiming nonpaying users, whether they are legacy or pirates or share gains frankly in that space and where we have to take it from someone else. I think, in the construction market, that's just an enormous amount of growth that's going to happen in that marketplace, so ahead of us we're really well positioned. But it's a big market and there's a lot of competitors in that space. I think there's an up market there for all of us to grow." That's more about growth potential. But the question is about mismatch of scale: the company is small relative to the demand it already serves.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| CRGO | Freightos Limited | Q1 2024 | 2024-05-20 | C+ |
| WRBY | Warby Parker Inc. | Q1 2024 | 2024-05-09 | A |
| LTRX | Lantronix, Inc. | Q3 2024 | 2024-04-29 | C |
| DASH | DoorDash, Inc. | Q3 2023 | 2023-11-01 | C+ |
| ADPT | Adaptive Biotechnologies Corporation | Q4 2022 | 2023-02-14 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| GDRX | GoodRx Holdings, Inc. | Q2 2022 | 2022-08-08 | F |
| FLYW | Flywire Corporation | Q1 2022 | 2022-05-14 | B+ |
| IRTC | iRhythm Technologies, Inc. | Q1 2022 | 2022-05-07 | C+ |
| HROW | Harrow Health, Inc. | Q4 2021 | 2022-03-10 | C |
| RELY | Remitly Global, Inc. | Q4 2021 | 2022-03-02 | B |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| HSTM | HealthStream, Inc. | Q3 2017 | 2017-10-24 | C |
HROW · Q4 2021 → YESThe question is about whether management describes a MISMATCH OF SCALE between the company and the demand it is already serving. Specifically, the company is currently supplying something enormous rel...YES The transcript shows management describing Harrow as already inside the large cataract surgery market (4.5–6 million procedures annually) with real, present-tense participation: thousands of customer relationships, shipping north of two million sterile ophthalmic units last year, and touching roughly one million cataract surgeries. They explicitly contrast this scale against 2021 revenues of $72.5 million, noting that even a modest share of the pass-through-eligible market (1 million procedures × premium pricing) would produce “a big number” and drive revenues “more than double” in the near term. They treat the current business as only the “earliest sliver” of what they are already positioned inside, with the binding question being how much of the existing flow they can capture rather than whether the flow exists. This meets both criteria. The answer is YES. The transcript shows management describing Harrow as already inside the large cataract surgery market (4.
WRBY · Q1 2024 → YESThe question is about whether management describes a MISMATCH OF SCALE between the company and the demand it is already serving. Specifically, the company is currently supplying something enormous rel...YES The transcript explicitly states that the company is already inside the optical industry with real business (245 stores serving customers, 83% of stores offering exams, 2.36 million active customers, and growing revenue from glasses, contacts, and exams). Management then draws the size contrast directly, noting that even the longer 900-store target "would still represent a small fraction of the 45,000 optical shops in the U.S." and that over 50% of major metro areas have only one store.
HSTM · Q3 2017 → YESThe question is about whether management describes a MISMATCH OF SCALE between the company and the demand it is already serving. Specifically, the company is currently supplying something enormous rel...**YES** Management describes the company already being inside a much larger flow of activity (the 80 million-person healthcare workforce, of which 4.6 million are in post-acute settings) and explicitly treats the scale mismatch as the central point. They note their strong sales team is already a “steady contributor” to 4.